Triazolam and zolpidem: effects on
human memory and attentional
processes
by
Mintzer MZ, Griffiths RR
Department of Psychiatry and Behavioral Sciences,
Behavioral Biology Research
Center,
Johns Hopkins University School of Medicine,
Baltimore, MD 21224, USA.
mmintzer@jhmi.edu
Psychopharmacology (Berl) 1999 May; 144(1):8-19
ABSTRACT
RATIONALE: The imidazopyridine hypnotic zolpidem may produce less memory and
cognitive impairment than classic benzodiazepines, due to its relatively low
binding affinity for the benzodiazepine receptor subtypes found in areas of the
brain which are involved in learning and memory. OBJECTIVES: The study was
designed to compare the acute effects of single oral doses of zolpidem (5, 10,
20 mg/70 kg) and the benzodiazepine hypnotic triazolam (0.125, 0.25, and 0.5
mg/70 kg) on specific memory and attentional processes. METHODS: Drug effects on
memory for target (i.e., focal) information and contextual information (i.e.,
peripheral details surrounding a target stimulus presentation) were evaluated
using a source monitoring paradigm, and drug effects on selective attention
mechanisms were evaluated using a negative priming paradigm, in 18 healthy
volunteers in a double-blind, placebo-controlled, crossover design. RESULTS:
Triazolam and zolpidem produced strikingly similar dose-related effects on
memory for target information. Both triazolam and zolpidem impaired subjects'
ability to remember whether a word stimulus had been presented to them on the
computer screen or whether they had been asked to generate the stimulus based on
an antonym cue (memory for the origin of a stimulus, which is one type of
contextual information). The results suggested that triazolam, but not zolpidem,
impaired memory for the screen location of picture stimuli (spatial contextual
information). Although both triazolam and zolpidem increased overall reaction
time in the negative priming task, only triazolam increased the magnitude of
negative priming relative to placebo. CONCLUSIONS: The observed differences
between triazolam and zolpidem have implications for the cognitive and
pharmacological mechanisms underlying drug-induced deficits in specific memory
and attentional processes, as well for the cognitive and brain mechanisms
underlying these processes.
GAD
Alcohol
Zopiclone
Insomnia
Sedatives
Temazepam
Dumb drugs
Ambien drivers
Benzodiazepines
Zolpidem (Ambien)
Sedative hypnotics
Sleeping-pill hype?
Zolpidem v zopiclone
Zolpidem v brotizolam
Eszopiclone (Lunesta)
Drugs to treat insomnia
Sleep maintenance insomnia
Zolpidem (Ambien): structure
Anxiolytics and antidepressants
Zolpidem (Ambien) and zopiclone (Imovane): weak antinociceptive effect
Refs
HOME
HedWeb
Future Opioids
BLTC Research
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family